IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.516
NA - Nord America 7.226
AS - Asia 5.427
SA - Sud America 945
Continente sconosciuto - Info sul continente non disponibili 472
AF - Africa 67
OC - Oceania 5
Totale 26.658
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.587
US - Stati Uniti d'America 6.992
SG - Singapore 1.819
IT - Italia 1.316
IE - Irlanda 1.109
CN - Cina 1.002
VN - Vietnam 879
HK - Hong Kong 829
BR - Brasile 772
GB - Regno Unito 413
DE - Germania 328
KR - Corea 290
IN - India 183
UA - Ucraina 175
FR - Francia 121
CA - Canada 115
JP - Giappone 113
GR - Grecia 83
FI - Finlandia 72
NL - Olanda 62
TR - Turchia 55
AR - Argentina 53
MX - Messico 48
SE - Svezia 45
BD - Bangladesh 44
EC - Ecuador 31
ID - Indonesia 31
RO - Romania 29
CO - Colombia 28
PL - Polonia 28
ES - Italia 27
AT - Austria 23
PK - Pakistan 23
BE - Belgio 22
CZ - Repubblica Ceca 18
IQ - Iraq 18
ZA - Sudafrica 18
EG - Egitto 16
VE - Venezuela 16
CR - Costa Rica 14
IR - Iran 14
LT - Lituania 14
CL - Cile 11
JM - Giamaica 11
PE - Perù 11
AZ - Azerbaigian 10
SA - Arabia Saudita 10
TT - Trinidad e Tobago 10
AE - Emirati Arabi Uniti 9
MY - Malesia 9
PH - Filippine 9
PY - Paraguay 9
TW - Taiwan 9
UZ - Uzbekistan 9
MA - Marocco 8
PT - Portogallo 8
CH - Svizzera 7
HN - Honduras 7
UY - Uruguay 7
BO - Bolivia 6
IL - Israele 6
KZ - Kazakistan 6
NP - Nepal 6
OM - Oman 6
TN - Tunisia 6
AU - Australia 5
DK - Danimarca 5
JO - Giordania 5
KG - Kirghizistan 5
PR - Porto Rico 5
TH - Thailandia 5
BB - Barbados 4
EE - Estonia 4
KE - Kenya 4
LB - Libano 4
SV - El Salvador 4
CY - Cipro 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
MK - Macedonia 3
RS - Serbia 3
AM - Armenia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
PA - Panama 2
SC - Seychelles 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
UG - Uganda 2
AG - Antigua e Barbuda 1
AL - Albania 1
Totale 26.167
Salva come PNG Salva come JPEG
Città #
Moscow 3.009
Dublin 1.096
San Jose 1.030
Singapore 817
Hong Kong 807
Santa Clara 666
Ashburn 641
Council Bluffs 419
Chandler 400
Jacksonville 294
Ho Chi Minh City 292
Seoul 283
Hanoi 218
Naples 205
New York 194
The Dalles 193
Princeton 178
Milan 163
Hefei 161
Roxbury 148
Beijing 142
Dallas 124
Bremen 98
Los Angeles 98
Bengaluru 93
Caserta 83
Cambridge 82
São Paulo 76
Medford 73
Munich 64
Da Nang 62
Ann Arbor 58
Chicago 51
Wilmington 51
Des Moines 49
Memphis 45
Atlanta 44
Haiphong 42
Orem 42
Amsterdam 37
Falkenstein 36
Miano 36
Frankfurt am Main 32
Boardman 30
Napoli 29
Montreal 28
Nanjing 28
Phoenix 28
Rome 26
Redwood City 25
Woodbridge 25
Helsinki 24
London 24
Washington 23
Toronto 22
Brussels 21
Nuremberg 21
Chennai 20
Jinan 20
Kochi 20
Brooklyn 19
Denver 19
Houston 19
Tokyo 19
Mountain View 18
Warsaw 18
Brasília 17
Florence 17
Hải Dương 17
Aversa 16
Belo Horizonte 16
Buffalo 15
Rio de Janeiro 15
Boston 14
Shenyang 14
Tianjin 14
Turku 14
Guayaquil 13
Hillsboro 13
Salvador 13
Shanghai 13
Curitiba 12
Lahore 12
Manchester 12
Mexico City 12
Porto Alegre 12
Salerno 12
Seattle 12
Giugliano In Campania 11
Nha Trang 11
Norwalk 11
Philadelphia 11
San Francisco 11
Stockholm 11
Thái Nguyên 11
Biên Hòa 10
Changsha 10
Dhaka 10
Hangzhou 10
Monserrato 10
Totale 13.690
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori and skin disorders: a comprehensive review of the available literature 238
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 228
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 220
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 216
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 209
What changed in the Italian internal medicine and geriatric wards during the lockdown 207
Bartter syndrome 205
A genic and epigenetic combination therapy for liver cancer 205
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 199
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 196
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 191
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 187
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 175
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 174
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 173
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 173
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 173
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 172
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 172
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 172
Chronic HCV infection and neurological and psychiatric disorders: an overview. 171
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 170
Predictors of early and late hepatocellular carcinoma recurrence 169
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 168
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 168
Sonoporation by microbubbles as gene therapy approach against liver cancer 168
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 168
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 167
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 167
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 167
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 164
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 163
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 162
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 162
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 162
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 162
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 162
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 161
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 161
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 161
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 160
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 159
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 158
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 156
[Next Generation Sequencing and ADPKD] 156
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 155
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 155
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 154
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 154
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 154
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 154
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 151
Chronic Hepatitis C Virus Infection and Depression. 150
Spirometry in elderly laryngectomized patients: A feasibility study 149
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 149
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 148
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 148
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 147
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 146
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 146
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 145
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 145
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 145
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 144
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 144
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 143
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 143
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 142
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 142
HCC and molecular targeting therapies: Back to the future 142
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 141
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 141
Cardiovascular benefits from gliflozins: Effects on endothelial function 141
Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 140
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 140
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 140
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 139
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 138
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 138
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 137
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 137
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 136
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 136
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 136
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 135
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 134
Antibiotic use and associated factors in a large sample of hospitalised older people 134
HCV-related steatosis and risk of atherosclerosis 133
Association between the spread of COVID-19 and weather-climatic parameters 133
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 131
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 130
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 129
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 129
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 129
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 128
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 126
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress 126
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study 126
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 126
Renal handling of uric acid 125
Totale 15.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022919 0 0 0 27 297 20 15 23 71 64 84 318
2022/20231.940 179 61 55 86 238 121 6 98 993 21 35 47
2023/20241.111 84 30 55 64 306 169 36 38 21 40 92 176
2024/20253.362 29 65 18 59 524 396 479 308 513 399 319 253
2025/202614.932 622 713 710 665 1.280 7.931 952 589 714 316 278 162
2026/20272.576 290 253 992 1.041 0 0 0 0 0 0 0 0
Totale 26.658